MPI of Biochemistry, LDC and Qurient Close License Deal on a New Compound against Metastatic Cancers

The Max Planck Institute of Biochemistry (MPIB), the Lead Discovery Center GmbH (LDC) and Qurient Co., Ltd have entered into a license agreement providing Qurient with world-wide